405 related articles for article (PubMed ID: 25551618)
1. Efficacy of combined vancomycin and fosfomycin against methicillin-resistant Staphylococcus aureus in biofilms in vivo.
Shi J; Mao NF; Wang L; Zhang HB; Chen Q; Liu H; Tang X; Jin T; Zhu CT; Li FB; Sun LH; Xu XM; Xu YQ
PLoS One; 2014; 9(12):e113133. PubMed ID: 25551618
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
Tang HJ; Chen CC; Cheng KC; Toh HS; Su BA; Chiang SR; Ko WC; Chuang YC
J Antimicrob Chemother; 2012 Apr; 67(4):944-50. PubMed ID: 22258931
[TBL] [Abstract][Full Text] [Related]
4. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Morikawa K; Nonaka M; Yoshikawa Y; Torii I
Int J Antimicrob Agents; 2005 Jan; 25(1):44-50. PubMed ID: 15620825
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Linezolid and Fosfomycin in Catheter-Related Biofilm Infection Caused by Methicillin-Resistant Staphylococcus aureus.
Chai D; Liu X; Wang R; Bai Y; Cai Y
Biomed Res Int; 2016; 2016():6413982. PubMed ID: 27366751
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y
BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
[TBL] [Abstract][Full Text] [Related]
9. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.
Mihailescu R; Furustrand Tafin U; Corvec S; Oliva A; Betrisey B; Borens O; Trampuz A
Antimicrob Agents Chemother; 2014 May; 58(5):2547-53. PubMed ID: 24550327
[TBL] [Abstract][Full Text] [Related]
10. Multiple Low Frequency Ultrasound Enhances Bactericidal Activity of Vancomycin against Methicillin-Resistant
Wang J; Wen K; Liu X; Weng CX; Wang R; Cai Y
Biomed Res Int; 2018; 2018():6023101. PubMed ID: 30364019
[TBL] [Abstract][Full Text] [Related]
11. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ
Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.
Poeppl W; Lingscheid T; Bernitzky D; Schwarze UY; Donath O; Perkmann T; Kozakowski N; Plasenzotti R; Reznicek G; Burgmann H
Antimicrob Agents Chemother; 2014 Sep; 58(9):5111-6. PubMed ID: 24936591
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic assessment of vancomycin-rifampicin combination against methicillin resistant Staphylococcus aureus biofilm: a parametric response surface analysis.
Salem AH; Elkhatib WF; Noreddin AM
J Pharm Pharmacol; 2011 Jan; 63(1):73-9. PubMed ID: 21155818
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model.
Salem AH; Elkhatib WF; Ahmed GF; Noreddin AM
J Chemother; 2010 Aug; 22(4):238-42. PubMed ID: 20685626
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin fails to eradicate mature biofilm formed by methicillin-resistant Staphylococcus aureus.
Reiter KC; Sambrano GE; Villa B; Paim TG; de Oliveira CF; d'Azevedo PA
Rev Soc Bras Med Trop; 2012; 45(4):471-4. PubMed ID: 22930045
[TBL] [Abstract][Full Text] [Related]
17. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
Tellis M; Joseph J; Khande H; Bhagwat S; Patel M
J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
[TBL] [Abstract][Full Text] [Related]
18. Stimulated phase-shift acoustic nanodroplets enhance vancomycin efficacy against methicillin-resistant
Guo H; Wang Z; Du Q; Li P; Wang Z; Wang A
Int J Nanomedicine; 2017; 12():4679-4690. PubMed ID: 28721044
[TBL] [Abstract][Full Text] [Related]
19. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
